Unraveling the temporal pattern of diet-induced insulin resistance in individual organs and cardiac dysfunction in C57BL/6 mice

Diabetes

Volumn 54, Issue 12, 2005, Pages 3530-3540

  Park, So Young ^a,e   Cho, You Ree ^a   Kim, Hyo Jeong ^a   Higashimori, Takamasa ^a   Danton, Cheryl ^a   Lee, Mi Kyung ^a   Dey, Asim ^b   Rothermel, Beverly ^b   Kim, Young Bum ^c   Kalinowski, April ^a   Russell, Kerry S ^a   Kim, Jason K ^a,d  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^c HARVARD MEDICAL SCHOOL   (United States)

^d PENN STATE COLLEGE OF MEDICINE   (United States)

^e Yeungnam University College of Medicine   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPOCYTOKINE; ADIPONECTIN; GLUCOSE TRANSPORTER 4; LEPTIN; PROTEIN KINASE B; RESISTIN; TRIACYLGLYCEROL;

ADIPOSE TISSUE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; DIET; FAT CONTENT; GLUCOSE HOMEOSTASIS; GLUCOSE METABOLISM; HEART DISEASE; HEART FUNCTION; HYPERGLYCEMIA; HYPERLEPTINEMIA; INSULIN RESISTANCE; LIPID DIET; LIPID METABOLISM; MALE; MOUSE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OBESITY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SKELETAL MUSCLE;

ADIPOSE TISSUE; ANIMAL FEED; ANIMALS; BLOOD GLUCOSE; DIETARY FATS; GLUCOSE; GLUCOSE CLAMP TECHNIQUE; HEART; HEART DISEASES; INSULIN; INSULIN RESISTANCE; MICE; MICE, INBRED C57BL; MYOCARDIUM; ORGAN SPECIFICITY;

EID: 33644672230     PISSN: 00121797     EISSN: 00121797     Source Type: Journal    
DOI: 10.2337/diabetes.54.12.3530     Document Type: Article

References (54)

1. Wild S, Roglic G, Green A, Sicree R, King H: Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care 27:1047-1053, 2004
2. Taegtmeyer H, Razeghi P: Heart disease in diabetes: resist the beginnings. J Am Col Cardiol 43:315, 2004
3. Pi-Sunyer FX: The obesity epidemic: pathophysiology and consequences of obesity. Obes Res 10:97S-104S, 2002
4. Sowers JR: Obesity as a cardiovascular risk factor. Am J Med 115:37S-41S, 2003
5. Kahn CR: Insulin action, diabetogenes, and the cause of type II diabetes. Diabetes 43:1066-1084, 1994
6. Reaven GM: Role of insulin resistance in human diabetes. Diabetes 37:1595-1607, 1988
7. Boden G: Role of fatty acids in the pathogenesis of insulin resistance and NIDDM. Diabetes 46:3-10, 1997
8. Terrettaz J, Jeanrenaud B: In vivo hepatic and peripheral insulin resistance in genetically obese (fa/fa) rats. Endocrinology 112:1346-1351, 1983
9. Kerouz NJ, Horsch D, Pons S, Kahn CR: Differential regulation of insulin receptor substrates-1 and -2 (IRS-1 and IRS-2) and phosphatidylinositol 3-kinase isoforms in liver and muscle of obese diabetic (ob/ob) mouse. J Clin Invest 100:3164-3172, 1997
10. Storlien LH, James DE, Burleigh KM, Chisholm DJ, Kraegen EW: Fat feeding causes widespread in vivo insulin resistance, decreased energy expenditure, and obesity in rats. Am J Physiol 251:E576-E583, 1986
11. McGarry JD: What if Minkowski had been ageusic? An alternative angle on diabetes. Science 258:766-770, 1992
12. Boden G, Shulman GI: Free fatty acids in obesity and type 2 diabetes: defining their role in the development of insulin resistance and beta-cell dysfunction. Eur J Clin Invest 32:14-23, 2002
13. Kraegen EW, Cooney GJ, Ye J, Thompson AL: Triglycerides, fatty acids and insulin resistance: hyperinsulinemia. Exp Clin Endocrinol Diabetes 109:S516-S526, 2001
14. Hotamisligil GS, Shargill NS, Spiegelman BM: Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance. Science 259:87-91, 1993
15. Steppan CM, Lazar MA: The current biology of resistin. J Intern Med 255:439-447, 2004
16. Yamauchi T, Kamon J, Waki H, Terauchi Y, Kubota N, Hara K, Mori Y, Ide T, Murakami K, Tsuboyama-Kasaoka N: The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity. Nat Med 7:941-946, 2001
17. Kern PA, Ranganathan S, Li C, Wood L, Ranganathan G: Adipose tissue tumor necrosis factor and interleukin-6 expression in human obesity and insulin resistance. Am J Physiol 280:E745-E751, 2001
18. Kim HJ, Higashimori T, Park SY, Choi H, Dong J, Kim YJ, Noh HL, Cho YR, Cline G, Kim YB, Kim JK: Differential effects of interleukin-6 and -10 on skeletal muscle and liver insulin action in vivo. Diabetes 53:1060-1067, 2004
19. Quinones-Galvan A, Ferrannini E: Metabolic effects of glucose-insulin infusions: myocardium and whole body. Curr Opin Clin Nutr Metab Care 4:157-163, 2001
20. Taegtmeyer H: Energy metabolism of the heart: from basic concepts to clinical applications. Curr Probl Cardiol 19:59-113, 1994
21. Stanley WC, Lopaschuk GD, McCormack JG: Regulation of energy substrate metabolism in the diabetic heart. Cardiovasc Res 34:25-33, 1997
22. Katz BB, Stenbit AE, Hatton K, DePinho R, Charron MJ: Cardiac and adipose tissue abnormalities but not diabetes in mice deficient in GLUT4. Nature 377:151-155, 1995
23. Abel ED, Kaulbach HC, Tian R, Hopkins JCA, Duffy J, Doetschman T, Minnemann T, Boers M-E, Hadro E, Oberste-Berghaus C, Quist W, Lowell BB, Ingwal JS, Kahn BB: Cardiac hypertrophy with preserved contractile function after selective deletion of GLUT4 from the heart. J Clin Invest 104:1703-1714, 1999
24. Belke DD, Betuing S, Tuttle MJ, Graveleau C, Young ME, Pham M, Zhang D, Cooksey RC, McClain DA, Litwin SE, Taegtmeyer H, Severson D, Kahn CR, Abel ED: Insulin signaling coordinately regulates cardiac size, metabolism, and contractile protein isoforms expression. J Clin Invest 109:629-639, 2002
25. Kolter T, Uphues I, Eckel J: Molecular analysis of insulin resistance in isolated ventricular cardiomyocytes of obese Zucker rats. Am J Physiol 273:E59-E67, 1997
26. Ohtake T, Yokoyama I, Watanabe, Momose T, Serezawa T, Nishikawa J, Sasaki Y: Myocardial glucose metabolism in noninsulin-dependent diabetes mellitus patients evaluated by FDG-PET. J Nucl Med 36:456-463, 1995
27. Iozzo P, Chareonthaitawee P, Dutka D, Betteridge DJ, Ferrannini E, Camici PG: Independent association of type 2 diabetes and coronary artery disease with myocardial insulin resistance. Diabetes 51:3020-3024, 2002
28. Rodrigues B, McNeill JH: The diabetic heart: metabolic causes for the development of a cardiomyopathy. Cardiovasc Res 26:913-922, 1992
29. Taegtmeyer H, Passmore JM: Defective energy metabolism of the heart in diabetes. Lancet 1:139-141, 1985
30. Lopaschuk GD: Abnormal mechanical function in diabetes: relationship to altered myocardial carbohydrates/lipid metabolism. Coron Artery Dis 7:116-123, 1996
31. Park S-Y, Cho Y-R, Finck BN, Kim H-J, Higashimori T, Hong E-G, Lee M-K, Danton C, Deshmukh S, Cline GW, Wu JJ, Bennett AM, Rothermel B, Kalinowski A, Russell KS, Kim Y-B, Kelly DP, Kim JK: Cardiac-specific overexpression of peroxisome proliferator-activated receptor-α causes insulin resistance in heart and liver. Diabetes 54:2514-2524, 2005
32. Kim YB, Shulman GI, Kahn BB: Fatty acid infusion selectively impairs insulin action on Akt1 and protein kinase C λ/ζ but not on glycogen synthase. J Biol Chem 277:32915-32922, 2002
33. Minokoshi Y, Kim Y-B, Peroni OD, Fryer LGD, Muller C, Carling D, Kahn BB: Leptin stimulates fatty-acid oxidation by activating AMP-activated protein kinase. Nature 415:339-343, 2002
34. Kim JK, Fillmore JJ, Chen Y, Yu C, Moore IK, Pypaert M, Lutz EP, Kako Y, Velez-Carrasco W, Goldberg IJ, Breslow JL, Shulman GI: Tissue-specific overexpression of lipoprotein lipase causes tissue-specific insulin resistance. Proc Natl Acad Sci U S A 98:7522-7527, 2001
35. Samuel VT, Liu Z-X, Qu X, Elder BD, Bilz S, Befroy D, Romanelli AJ, Shulman GI: Mechanism of hepatic insulin resistance in non-alcoholic fatty liver disease. J Biol Chem 279:32345-32353, 2004
36. Cho H, Mu J, Kim JK, Thorvaldsen JL, Chu Q, Crenshaw EB III, Kaestner KH, Bartolomei MS, Shulman GI, Birnbaum MJ: Insulin resistance and diabetes mellitus-like syndrome in mice lacking Akt2 (PKBβ). Science 292:1728-1731, 2001
37. Sader S, Nian M, Liu P: Leptin: a novel link between obesity, diabetes, cardiovascular risk, and ventricular hypertrophy. Circulation 108:644-646, 2003
38. Combs TP, Berg AH, Rajala MW, Klebanov S, Iyengar P, Jimenez-Chillaron JC, Patti ME, Klein SL, Weinstein RS, Scherer PE: Sexual differentiation, pregnancy, calorie restriction, and aging affect the adipocyte-specific secretory protein adiponectin. Diabetes 52:268-276, 2003
39. Finck BN, Han X, Courtois M, Aimond F, Nerbonne JM, Kovacs A, Gross RW, Kelly DP: A critical role for PPARα-mediated lipotoxicity in the pathogenesis of diabetic cardiomyopathy: modulation of dietary fat content. Proc Natl Acad Sci U S A 100:1226-1231, 2003
40. Zhou Y-T, Grayburn P, Karim A, Shimabukuro M, Higa M, Baetens D, Orci L, Unger RH: Lipotoxic heart disease in obese rats: implications for human obesity. Proc Natl Acad Sci U S A 97:1784-1789, 2000
41. Hardt SE, Sadoshima J: Glycogen synthase kinase-3beta: a novel regulator of cardiac hypertrophy and development. Circ Res 90:1055-1063, 2002
42. Sweeney JH: Dietary factors that influence the dextrose tolerance test. Arch Intern Med 40:818-830, 1927
43. Kraegen EW, Clark PW, Jenkins AB, Daley EA, Chisholm DJ, Storlien LH: Development of muscle insulin resistance after liver insulin resistance in high-fat-fed rats. Diabetes 40:1397-1403, 1991
44. Koyama K, Chen G, Lee Y, Unger RH: Tissue triglycerides, insulin resistance, and insulin production: implications for hyperinsulinemia of obesity. Am J Physiol 273:E708-E713, 1997
45. Kim JK, Gimeno RE, Higashimori T, Kim H-J, Choi H, Punreddy S, Mozell RL, Tan G, Stricker-Kronrad A, Hirsch DJ, Fillmore JJ, Liu Z-X, Dong J, Cline G, Stahl A, Lodish HF, Shulman GI: Inactivation of fatty acid transport protein 1 prevents fat-induced insulin resistance in skeletal muscle. J Clin Invest 113:756-763, 2004
46. Muse ED, Obici S, Bhanot S, Monia BP, McKay RA, Rajala MW, Scherer PE, Rossetti L: Role of resistin in diet-induced hepatic insulin resistance. J Clin Invest 114:232-239, 2004
47. Park S-Y, Kim H-J, Wang S, Higashimori T, Dong J, Kim Y-J, Cline GW, Li H, Prentki M, Shulman GI, Mitchell GA, Kim JK: Hormone-sensitive lipase knockout mice have increased hepatic insulin sensitivity and are protected from short-term diet-induced insulin resistance in skeletal muscle and heart. Am J Physiol 289:E30-E39, 2005
48. Berger J, Moller DE: The mechanisms of action of PPARs. Annu Rev Med 53:409-435, 2002
49. Finck BN, Lehman JJ, Leone TC, Welch MJ, Bennett MJ, Kovacs A, Han X, Gross RW, Kozak R, Lopaschuk GD, Kelly DP: The cardiac phenotype induced by PPARα overexpression mimics that caused by diabetes mellitus. J Clin Invest 109:121-130, 2002
50. Matsui T, Li L, Wu JC, Cook SA, Nagoshi T, Picard MH, Liao R, Rosenzweig A: Phenotypic spectrum caused by transgenic overexpression of activated Akt in the heart. J Biol Chem 277:22896-22901, 2002
51. Winder WW, Hardie DG: AMP-activated protein kinase, a metabolic master switch: possible roles in type 2 diabetes. Am J Physiol 277:E1-E10, 1999
52. Ruderman NB, Saha AK, Vavvas D, Witters LA: Malonyl CoA, fuel sensing, and insulin resistance. Am J Physiol 276:E1-E18, 1999
53. Vettor R, Fabris R, Serra R, Lombardi AM, Tonello C, Granzotto M, Marzolo MO, Carruba MO, Ricquier D, Federspil G, Nisoli E: Changes in FAT/CD36, UCP2, UCP3 and GLUT4 gene expression during lipid infusion in rat skeletal and heart muscle. Int J Obes Relat Metab Disord 26:838-847, 2002
54. Kaul N, Siveski-Illiskovic N, Hill M, Khaper N, Seneviratne C, Singal PK: Probucol treatment reverses antioxidant and functional deficit in diabetic cardiomyopathy. Mol Cell Biochem 42:283-288, 1996